Etripamil (hydrochloride)
Etripamil (MSP-2017) hydrochloride is a short-acting, L-type calcium channel antagonist that can be used in the study of paroxysmal supraventricular tachycardia (PSVT) . Etripamil hydrochloride inhibits calcium influx through slow calcium channels, thereby slowing atrioventricular node conduction and prolonging the atrioventricular node refractory period.
Product Specifications
CAS Number
2560549-35-9
Product Name Alternative
MSP-2017 (hydrochloride) ; (-) -MSP-2017 (hydrochloride)
UNSPSC
12352005
Target
Calcium Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
COC(C1=CC=CC(CCN(C)CCC[C@@](C#N)(C2=CC(OC)=C(C=C2)OC)C(C)C)=C1)=O.Cl
Molecular Formula
C27H37ClN2O4
Molecular Weight
489.05
References & Citations
[1]Pokorney S D, et al. CO143 Impact of Investigational, at-Home, Self-Administered, Intranasal Etripamil on the Need for Additional Medical Intervention in Patients with Supraventricular Tachycardia[J]. Value in Health, 2023, 26 (6) : S41.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401129 100 µg
Claudin 5 (CLDN5) (NM_003277) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC470245-500 1x 500 µL
SHBG (Sex Hormone Binding Globulin) (SHBG/245), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 